G. d'Albasio

发表

Effect of Anti-TNF Therapy and Vitamin D Derivatives on the Proliferation of Peripheral Blood Mononuclear Cells in Crohn's Disease

A. Bonanomi, S. Bagnoli, C. Treves, 2004, Digestive Diseases and Sciences.

A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92).

D. Palli, A. Amorosi, A. Messori, 1996, Scandinavian journal of gastroenterology.

Abstracts of posters

J. M. Badía, L. Ponz, G. Serratrice, 1993, Pharmacy World and Science.

Oral beclometasone dipropionate in the treatment of extensive and left‐sided active ulcerative colitis: a multicentre randomised study

F. Manguso, P. Gionchetti, F. Rizzello, 2003, Alimentary pharmacology & therapeutics.

Interaction among vitamin D(3) analogue KH 1060, TNF-alpha, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients.

A. Bonanomi, S. Bagnoli, C. Treves, 2006, International immunopharmacology.

Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis.

A. Messori, G. Trallori, C. Brignola, 1994, The American journal of gastroenterology.

Hodgkin's disease risk is increased in patients with ulcerative colitis.

D. Palli, G. Masala, A. Amorosi, 2000, Gastroenterology.

The Vitamin D analogue TX 527 blocks NF-κB activation in peripheral blood mononuclear cells of patients with Crohn's disease

A. Bonanomi, S. Bagnoli, A. Verstuyf, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis

A. Bonanomi, C. Treves, A. Celli, 2002, American Journal of Gastroenterology.

Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn’s disease patients: the Florence IBD study 1978–2001

D. Palli, I. Zanna, G. Masala, 2004, Gut.

Suppressive effect of 1,25-dihydroxyvitamin D3 and its analogues EB 1089 and KH 1060 on T lymphocyte proliferation in active ulcerative colitis.

A. Bonanomi, C. Treves, M. Stio, 2001, Biochemical pharmacology.

Epidemiology of inflammatory bowel disease over a 10-year period in Florence (1978-1987).

D. Palli, G. Trallori, A. Russo, 1991, The Italian journal of gastroenterology.

Incidence and prevalence of inflammatory bowel disease in florence from 1978 to 1992

D. Palli, G. Trallori, A. Bonanomi, 1995 .

Maintenance treatment of ulcerative proctitis with mesalazine suppositories: a double-blind placebo-controlled trial

G. Porro, M. Campieri, G. Sturniolo, 1998, American Journal of Gastroenterology.

Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group.

M. Scribano, S. Ardizzone, M. Cottone, 1995, Gastroenterology.

Topical butyrate improves efficacy of 5‐ASA in refractory distal ulcerative colitis: results of a multicentre trial

V. Annese, R. D'Incà, R. Caprilli, 2003, European journal of clinical investigation.

Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis

M. Campieri, L. Barbara, A. Pera, 1993, Digestive Diseases and Sciences.

Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial.

G. Porro, G. Sturniolo, C. Prantera, 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Combined therapy with 5-aminosalicylic tablets and enemas for maintaining remission in ulcerative colitis.

C. Varini, G. Trallori, G. d'Albasio, 1991, The Italian journal of gastroenterology.

Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal

G. Porro, S. Travis, V. Annese, 2009, The American Journal of Gastroenterology.

General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence study

D. Palli, G. Masala, G. Trallori, 1998, Gut.

Susceptibility to Refractory Ulcerative Colitis Is Associated with Polymorphism in the hMLH1 Mismatch Repair Gene

M. Genuardi, R. Sestini, M. Milla, 2004, Inflammatory bowel diseases.

Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study.

A. Amorosi, A. Messori, M. Milla, 1997, The American journal of gastroenterology.

Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis

M. Milla, G. Trallori, G. d'Albasio, 1990, Diseases of the colon and rectum.

Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis.

A. Messori, M. Milla, G. Trallori, 1996, Scandinavian journal of gastroenterology.

Spondyloarthritis in patients with ulcerative colitis.

U. Serni, M. Benucci, G. Trallori, 1997, Italian journal of gastroenterology and hepatology.

Intermittent versus continuous 5-aminosalicylic acid treatment for maintaining remission in ulcerative colitis.

A. Amorosi, A. Messori, G. Trallori, 1994, The Italian journal of gastroenterology.